Lataa...
Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting
BACKGROUND: This study was designed to mainly evaluate the activity and safety of olanzapine compared with 5-hydroxytryptamine3(5-HT(3)) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting(CINV) in patients receiving highly or moderately emetogenic chemotherapy (HEC or ME...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2761865/ https://ncbi.nlm.nih.gov/pubmed/19775450 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-9966-28-131 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|